Concepedia

Rafał Zieliński

RZ

Statistics

Publications

21

Citations

903

H-Index

16

Active since

2002

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Harvard University

Beth Israel Deaconess Medical Center

John Paul II Catholic University of Lublin

Wojskowy Instytut Higieny i Epidemiologii

Rafał Zieliński is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2002–2024

21

Publications

21

Epigenetic Reprogramming of Cancer-Associated Fibroblasts Deregulates Glucose Metabolism and Facilitates Progression of Breast Cancer

Lisa M. Becker, Joyce T. O’Connell, Annie P. Vo et al. · Cell Reports · 2020 · 283 citations · Full text

, , +17

An enolase inhibitor for the targeted treatment of ENO1-deleted cancers

Yu-Hsi Lin, Nikunj Satani, Naima Hammoudi et al. · Nature Metabolism · 2020 · 103 citations · Full text

, , +4

Active Targeting Using HER‐2‐Affibody‐Conjugated Nanoparticles Enabled Sensitive and Specific Imaging of Orthotopic HER‐2 Positive Ovarian Tumors

Minati Satpathy, Liya Wang, Rafał Zieliński et al. · Small · 2013 · 68 citations

, , +17

Radiation with STAT3 Blockade Triggers Dendritic Cell–T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy

Martina Ott, Cynthia Kassab, Anantha Marisetty et al. · Clinical Cancer Research · 2020 · 51 citations · Full text

, , +17

ATPS-68COMBINATION OF TOPOISOMERASE II POISON BERUBICIN WITH STAT3 INHIBITOR WP1066BLOCKS POTENTLY TUMOR GROWTH IN GMB MODELS

Rafał Zieliński, Stanisław Skóra, Aleksandra Rusin et al. · Neuro-Oncology · 2015 · 43 citations · Full text

, , +17

1–5 of 21